The Technical Field "動物" had 150 patent application filings in the most recent period (2023-01-01 to 2023-03-31). This is a significantly decreased of -458 filings (-75.3%) over 608 they had in the same period of the previous year (2022-01-01 to 2022-03-31). This report also includes technical terms related to " 禽獣 ", " アニマル " in the search set.
The highest number of filings in 2016 with 3,610 cases, and their lowest number in 2022 with 2,177 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 14,781 cases in total) is 2,464, and the median is 2,770. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 2,464 patents |
Std Dev | 1,031 |
COV | 0.4 |
Year | Cases | YOY |
---|---|---|
2022 year | 2,177 cases | -19.16 % |
2021 year | 2,693 cases | -5.44 % |
2020 year | 2,848 cases | -16.51 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 動物 for the period of the last 10 years (2014-01-01 to 2024-11-30). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 動物, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The changes in the number of patent filings of 動物 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
This patent analysis report was created for a patent search set of 28,994 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 動物 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 12 cases, followed by ジェネンテックインコーポレイテッド with 11 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 12 cases |
ジェネンテックインコーポレイテッド | 11 cases |
ファイザー・インク | 8 cases |
エフホフマン-ラロシュアーゲー | 6 cases |
武田薬品工業株式会社 | 5 cases |
ノバルティスアーゲー | 3 cases |
ロレアル | 2 cases |
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 215 cases, followed by ジェネンテックインコーポレイテッド with 214 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 215 cases |
ジェネンテックインコーポレイテッド | 214 cases |
エフホフマン-ラロシュアーゲー | 172 cases |
ノバルティスアーゲー | 171 cases |
武田薬品工業株式会社 | 158 cases |
ファイザー・インク | 112 cases |
ロレアル | 66 cases |
国立研究開発法人科学技術振興機構 | 11 cases |
グラクソグループリミテッド | 3 cases |
メルク・シャープ・エンド・ドーム・コーポレイション | 1 cases |
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 動物 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Among the top coapplicants, ジェネンテックインコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 11 cases, followed by エフホフマン-ラロシュアーゲー with 6 cases.
Name | Cases |
---|---|
ジェネンテックインコーポレイテッド | 11 cases |
エフホフマン-ラロシュアーゲー | 6 cases |
武田薬品工業株式会社 | 5 cases |
ノバルティスアーゲー | 3 cases |
ロレアル | 2 cases |
Among the top coapplicants, ジェネンテックインコーポレイテッド has the highest number of joint applications in the last for the target period (2014 to 2024) with 214 cases, followed by エフホフマン-ラロシュアーゲー with 172 cases.
Name | Cases |
---|---|
ジェネンテックインコーポレイテッド | 214 cases |
エフホフマン-ラロシュアーゲー | 172 cases |
ノバルティスアーゲー | 171 cases |
武田薬品工業株式会社 | 158 cases |
ロレアル | 66 cases |
メルク・シャープ・エンド・ドーム・コーポレイション | 1 cases |
Below is a ranking of the number of JP patent applications by 動物’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 動物’s top 7 coapplicants over the last 20 years.
動物 filed 158 joint applications with 武田薬品工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 75 cases in total) is 12.5, and the median is 11.5. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2018 with 28 cases, and their lowest number in 2022 with 4 cases.
Index | Value |
---|---|
Average | 12.5 patents |
Std Dev | 9.6 |
COV | 0.8 |
Year | Cases | YOY |
---|---|---|
2022 year | 4 cases | -33.3 % |
2021 year | 6 cases | -64.7 % |
2020 year | 17 cases | -10.53 % |
動物 filed 214 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 66 cases in total) is 11.0, and the median is 11.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 48 cases, and their lowest number in 2020 with 9 cases.
Index | Value |
---|---|
Average | 11.0 patents |
Std Dev | 6.2 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 11 cases | -47.6 % |
2021 year | 21 cases | +133 % |
2020 year | 9 cases | -18.18 % |
動物 filed 171 joint applications with ノバルティスアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 39 cases in total) is 6.5, and the median is 4.5. The coefficient of variation (standard deviation/mean) is 1.0, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 44 cases, and their lowest number in 2022 with 3 cases.
Index | Value |
---|---|
Average | 6.5 patents |
Std Dev | 6.4 |
COV | 1.0 |
Year | Cases | YOY |
---|---|---|
2022 year | 3 cases | -40.0 % |
2021 year | 5 cases | +25.00 % |
2020 year | 4 cases | -42.9 % |
動物 filed 66 joint applications with ロレアル for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 12 cases in total) is 2.0, and the median is 2.0. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 27 cases, and their lowest number in 2021 with 0 cases.
Index | Value |
---|---|
Average | 2.0 patents |
Std Dev | 1.7 |
COV | 0.9 |
Year | Cases | YOY |
---|---|---|
2022 year | 2 cases | - |
2021 year | 0 cases | -100 % |
2020 year | 5 cases | +150 % |
動物 filed 172 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 97 cases in total) is 16.2, and the median is 14.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2020 with 35 cases, and their lowest number in 2022 with 6 cases.
Index | Value |
---|---|
Average | 16.2 patents |
Std Dev | 11.9 |
COV | 0.7 |
Year | Cases | YOY |
---|---|---|
2022 year | 6 cases | -57.1 % |
2021 year | 14 cases | -60.0 % |
2020 year | 35 cases | +29.63 % |
The following shows JP patents held by 動物 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 動物’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 動物 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 6 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.7 times. The most recently Invalidation Trial patent is 特許6445123 "癌を治療するための方法及び組成物" (Invalidation Trial day 2023-11-25) , next is 特許6896700 "ワクチン組成物" (Invalidation Trial day 2023-01-27) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許6445123 | 癌を治療するための方法及び組成物 | 2023-11-25 |
2 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
3 | 特許4414623 | 病原微生物および抗微生物剤の検出法、抗微生物剤の薬効評価法ならびに抗微生物剤 | 2023-01-11 |
4 | 特許6203879 | 配列操作のための系、方法および最適化ガイド組成物のエンジニアリング | 2022-09-30 |
5 | 特許6813851 | 照明装置 | 2022-07-27 |
6 | 特許6692856 | RNA依存性標的DNA修飾およびRNA依存性転写調節のための方法および組成物 | 2022-02-25 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 5 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.8. The most invalidation trial patent is 特許6445123 "癌を治療するための方法及び組成物" (5 times) , and the next most invalidation trial patent is 特許6813851 "照明装置" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6445123 | 癌を治療するための方法及び組成物 | 5 times |
2 | 特許6813851 | 照明装置 | 1 times |
3 | 特許6896700 | ワクチン組成物 | 1 times |
4 | 特許6203879 | 配列操作のための系、方法および最適化ガイド組成物のエンジニアリング | 1 times |
5 | 特許6293103 | 自己緩衝タンパク質製剤 | 1 times |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 30 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7460770 "液体フィードストリーム中へのガスの再飽和" (Opposition day 2024-10-01) , next is 特許7391858 "ポリ硫酸化多糖類を用いた術後関節痛の処置" (Opposition day 2024-05-24) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7460770 | 液体フィードストリーム中へのガスの再飽和 | 2024-10-01 |
2 | 特許7391858 | ポリ硫酸化多糖類を用いた術後関節痛の処置 | 2024-05-24 |
3 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
4 | 特許7344565 | 未分化細胞検出法 | 2024-03-13 |
5 | 特許7342338 | 乳酸菌と脂肪酸を含む飼料及び組成物 | 2024-03-11 |
6 | 特許7340901 | 故人及び/又は動物の放置された部屋の消臭方法 | 2024-03-08 |
7 | 特許7301332 | DNAが編集された真核細胞を製造する方法、および当該方法に用いられるキット | 2024-01-04 |
8 | 特許7291217 | 足場非依存性細胞およびその使用 | 2023-12-14 |
9 | 特許7308185 | シリカ系艶消し剤及びそれを作製及び使用する方法 | 2023-12-13 |
10 | 特許7244922 | 化学修飾された一本鎖RNA編集オリゴヌクレオチド | 2023-09-20 |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 96 patents Protest from third parties. The average number of Protest is 1.4 times. The most recently Protest patent is 特表2022-500417 "咬筋肥大症の治療方法" (Protest day 2024-11-13) , next is 特開2023-110924 "情報処理装置、情報処理プログラム、および情報処理方法" (Protest day 2024-10-30) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 特表2022-500417 | 咬筋肥大症の治療方法 | 2024-11-13 |
2 | 特開2023-110924 | 情報処理装置、情報処理プログラム、および情報処理方法 | 2024-10-30 |
3 | 特表2023-546593 | ペットフード組成物 | 2024-10-28 |
4 | 特開2022-186756 | アルロース結晶の製造方法 | 2024-10-18 |
5 | 特許7037667 | STINGアダプタータンパク質を活性化するホスホン酸結合を有する3’3’環状ジヌクレオチド | 2024-10-09 |
6 | 特表2023-546414 | ペットフード組成物 | 2024-10-02 |
7 | 特開2024-067495 | 食品 | 2024-09-20 |
8 | 特表2022-521426 | 安定なタンパク質製剤 | 2024-09-17 |
9 | 特開2023-060015 | 眼科用組成物 | 2024-08-29 |
10 | 特開2024-028649 | DNAが編集された真核細胞を製造する方法、および当該方法に用いられるキット | 2024-08-28 |
11 | 特開2023-039780 | 二液型皮膚改善化粧料のための容器 | 2024-08-26 |
12 | 特開2023-183766 | 路面標示組成物 | 2024-08-22 |
13 | 特許7524213 | 下痢の防止及び処置における使用のためのビデンスピローサ及びそのファイトケミカル | 2024-08-01 |
14 | 特開2022-045380 | 集中力維持増進用組成物 | 2024-07-31 |
15 | 特表2023-532989 | 食品、花、及び植物の改善された保管及び/又は輸送 | 2024-07-26 |
16 | 特開2021-194000 | 加工食品生地および加工食品 | 2024-07-05 |
17 | 特開2024-077344 | 吸水成分が分散された油脂の層を備える米粒状食品 | 2024-06-13 |
18 | 特開2022-070778 | 炒め調理用組成物 | 2024-06-04 |
19 | 特開2023-025730 | 野菜含有調味料、及びその製造方法 | 2024-05-28 |
20 | 特開2024-045453 | 殺ウイルス有効性に対するアニオン性界面活性剤の影響 | 2024-05-23 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 186 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.4. The most protest patent is 特許7032618 "動物用コンタクトレンズ" (5 times) , and the next most protest patent is 特開2021-116296 "コロナウイルス感染の治療におけるファビピラビルの使用" (4 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許7032618 | 動物用コンタクトレンズ | 5 times |
2 | 特開2021-116296 | コロナウイルス感染の治療におけるファビピラビルの使用 | 4 times |
3 | 特開2021-138745 | ワクチン組成物 | 4 times |
4 | 特開2020-114266 | IgG Fcドメインを有する融合タンパク質の生産方法 | 4 times |
5 | 再公表2015/190483 | 眼科用水性組成物 | 4 times |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 390 patents Inspection from third parties. The average number of Inspection is 1.4 times. The most recently Inspection patent is 特表2022-516318 "カプセル化ポリヌクレオチド及び使用方法" (Inspection day 2024-11-22) , next is 特表2022-516199 "ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物" (Inspection day 2024-11-21) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 特表2022-516318 | カプセル化ポリヌクレオチド及び使用方法 | 2024-11-22 |
2 | 特表2022-516199 | ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物 | 2024-11-21 |
3 | 特表2022-500417 | 咬筋肥大症の治療方法 | 2024-11-18 |
4 | 特許6231007 | BCMAおよびCD3に対する結合分子 | 2024-11-15 |
5 | 特許7250736 | BCMAおよびCD3に対する結合分子 | 2024-11-15 |
6 | 特許6378087 | BCMAおよびCD3に対する結合分子 | 2024-11-15 |
7 | 特開2017-195889 | BCMAおよびCD3に対する結合分子 | 2024-11-15 |
8 | 特開2022-008533 | カゼインを含む組成物およびこれを作製する方法 | 2024-11-15 |
9 | 特表2022-513077 | クロストリジウム・ディフィシル多成分ワクチン | 2024-11-12 |
10 | 特表2022-540106 | メタレートイオン交換組成物を使用する、体液からコバルト、鉛、カドミウム及びクロムのイオンを除去する方法 | 2024-11-12 |
11 | 特表2023-504773 | 眼遺伝子送達のためのAAVベクター変異体 | 2024-11-07 |
12 | 特表2022-504139 | バイオフィルムの除去のためのHMGB1タンパク質誘導体 | 2024-11-05 |
13 | 特開2022-186756 | アルロース結晶の製造方法 | 2024-10-24 |
14 | 特許7037667 | STINGアダプタータンパク質を活性化するホスホン酸結合を有する3’3’環状ジヌクレオチド | 2024-10-22 |
15 | 特表2021-511827 | ミトコンドリア機能を向上させる組成物および方法 | 2024-10-17 |
16 | 特開2020-189881 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-11 |
17 | 特開2019-006777 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-11 |
18 | 特表2013-537518 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-11 |
19 | 特表2022-514331 | 多糖類と両性イオン性ポリマーをベースにしたヒドロゲル組成物およびその使用方法 | 2024-10-11 |
20 | 特開2017-043626 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-11 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 791 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.3. The most inspection patent is 特開2017-149726 "B細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療" (46 times) , and the next most inspection patent is 特開2015-110577 "癌を治療するための方法及び組成物" (11 times) .
- | No. | Title | |
---|---|---|---|
1 | 特開2017-149726 | B細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療 | 46 times |
2 | 特開2015-110577 | 癌を治療するための方法及び組成物 | 11 times |
3 | 再公表2019/172112 | 細胞凍結保存用溶液およびその利用 | 10 times |
4 | 特許6445123 | 癌を治療するための方法及び組成物 | 8 times |
5 | 特開2015-143266 | 化学療法誘導嘔吐を治療するためのパロノセトロン | 8 times |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 4,422 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.3. The most cited patent is 特許6522022 "弾球遊技機" (75 times) , and the next most cited patent is 特許6731819 "移動体軌道予測システム" (42 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6522022 | 弾球遊技機 | 75 times |
2 | 特許6731819 | 移動体軌道予測システム | 42 times |
3 | 特許6336640 | 生理学的信号のモニター方法 | 39 times |
4 | 特許7185009 | 細胞トランスフェクションのエレクトロポレーション装置及び方法 | 39 times |
5 | 特許6395765 | 配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化 | 36 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International